Related Post
Bio-Rad Laboratories is in talks to merge with fellow life-sciences organization Qiagen NV in a offer that would be well worth more than $10 billion, in accordance to persons familiar with the subject.
The talks have been likely on for a while but any agreement isn’t most likely for a further several months or more—and there may possibly not be one particular.
Tags: acquisitionsAcquisitions/MergersAcquisitions/Mergers/ShareholdingsapparatusBIOBio-Rad LaboratoriesBiotechnologyC&E Industry News FilterContent TypescorporateCorporate ActionsCorporate/Industrial NewsdiagnosticDiagnostic/Therapeutic DevicesFactiva Filtersgeneral newsGenomicsHealthcareHealthcare/Life Scienceshumanitiesindustrial newskwexclusivelife sciencesmedical devicesMedical Devices/Apparatusmedical diagnostic equipmentMedical Diagnostic Equipment/Suppliesmedical equipmentMedical Equipment/SuppliesmergersOwnership ChangespoliticalPolitical/General NewsQGENQiagensciencesSciences/Humanitiesshareholdingssuppliessyndtherapeutic devicesWSJ-PRO-WSJ.comwsjfinance-ws